Clinical and surrogate endpoints in future studies on outcome of carotid revascularization.
| Autor: | Ettorre L; Service of Vascular Surgery, Centro Vascolare Ticino, Ospedale Regionale di Lugano, sede Civico, Lugano, Switzerland., Giovannacci L; Service of Vascular Surgery, Centro Vascolare Ticino, Ospedale Regionale di Lugano, sede Civico, Lugano, Switzerland., van den Berg JC; Service of Interventional Radiology, Centro Vascolare Ticino, Ospedale Regionale di Lugano, sede Civico, Lugano, Switzerland - josua.vandenberg@eoc.ch.; Inselspital, Universitätsspital Bern Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Bern, Switzerland. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of cardiovascular surgery [J Cardiovasc Surg (Torino)] 2019 Jun; Vol. 60 (3), pp. 325-331. Date of Electronic Publication: 2019 Mar 01. |
| DOI: | 10.23736/S0021-9509.19.10910-X |
| Abstrakt: | This paper will provide a comparison of classical endpoints like stroke and mortality versus biochemical (non-STEMI) myocardial infarction and DW-MRI new brain lesions and will discuss the importance of cranial nerve lesion in CEA. An overview of possible endpoints of future randomized clinical trials will be given. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|